BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Investor
Nasdaq Welcomes Bellicum Pharmaceuticals, Inc. To The Nasdaq Stock Market 12/19/2014
Relmada Therapeutics Announces Results Of Annual Shareholders Meeting 12/19/2014
Hyperion Therapeutics (HPTX) Added To Nasdaq Biotechnology Index (NBI) 12/19/2014
PlasmaTech Biopharmaceuticals Announces Pricing Of $14,000,000 Public Offering And Listing On NASDAQ 12/19/2014
Soligenix (SNGX) Announces Pricing Of Public Offering Of Units 12/19/2014
AEterna Zentaris (AEZS) Receives Notification From NASDAQ Relating To Minimum Bid Price 12/19/2014
Novogen Limited (NVGN) Raises An Additional A$1.75m In Private Placement To US Institutions For Aggregate Private Placement Of A$5.85m 12/19/2014
GlaxoSmithKline (GSK) Reassure Investors That Dividend Is Safe As Analysts Question Payout 12/19/2014
Biotech Predictions for Large Cap Firms Include Medivation, Inc. (MDVN), Gilead Sciences, Inc. (GILD) 12/18/2014
Bellicum Pharmaceuticals, Inc. Prices Initial Public Offering Of 7,350,000 Shares Of Common Stock 12/18/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Completes Public Offering of Common Stock 12/18/2014
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 12/18/2014
Trillium Therapeutics Inc. To List Common Shares On The NASDAQ Capital Market Under The Symbol TRIL 12/18/2014
Cara Therapeutics, Inc. (CARA) Announces Addition To The NASDAQ Biotechnology Index 12/18/2014
CytoSorbents, Inc. Receives NASDAQ Listing Approval 12/18/2014
Xenetic Biosciences CEO Delivers “2014 – The Year In Review” Update To Investors And Stakeholders 12/18/2014
2015 Could Be Blockbuster Year for Alkermes plc (ALKS), Says Citi 12/17/2014
Lion Biotechnologies, Inc. Announces Pricing Of Underwritten Common Stock Offering 12/17/2014
Agios Pharmaceuticals (AGIO) Announces Closing Of Public Offering And Full Exercise Of Over-Allotment Option 12/17/2014
Alder Biopharmaceuticals Inc. Announces Addition To NASDAQ Biotechnology Index 12/17/2014
Relypsa, Inc. (RLYP) To Be Added To NASDAQ Biotechnology Index 12/17/2014
SAGE Therapeutics Added To NASDAQ Biotechnology Index 12/17/2014
Flexion Therapeutics (FLXN) Announces Exercise Of Underwriters' Over-Allotment Option And Closing Of Public Offering Of Common Stock 12/17/2014
LifeSci Index Partners, LLC Release: BioShares Launches Two New Biotechnology ETFs (Nasdaq: BBC, BBP) 12/17/2014
IGI Laboratories, Inc. Announces Closing Of $125 Million Of 3.75% Convertible Senior Notes Due 2019 12/17/2014
Novogen Limited (NVGN) Raises A$4.1 Million In Private Placement To US Institutions 12/17/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 12/17/2014
The Biotech Year in Review, According To Bernstein 12/16/2014
Eli Lilly (LLY) Sets Dates And Conference Calls For 2015 Financial Guidance And Fourth-Quarter 2014 Financial Results 12/16/2014
QLT Inc. (QLTI) Announces Results Of Annual General Meeting Of Shareholders 12/16/2014
Celladon Corporation Added To NASDAQ Biotechnology Index 12/16/2014
Kite Pharma, Inc. (KITE) Added To The NASDAQ Biotechnology Index 12/16/2014
Valeant (VRX) To Hold Conference Call To Announce 2015 Financial Guidance 12/16/2014
Alimera Sciences (ALIM) Added To NASDAQ Biotechnology Index 12/16/2014
Glucose Health, Inc. To Upgrade To OTCQB Venture Market 12/16/2014
Crescendo Biologics' Receives Further Investment From Astellas Venture Management To Develop Novel Humabody Therapeutics Targeting Immune Checkpoint Inhibitors 12/16/2014
Eli Lilly (LLY) Announces Dividend Increase 12/16/2014
K-Bro Declares December Dividend 12/16/2014
Foundation Medicine, Inc. (FMI) To Be Added To NASDAQ Biotechnology Index 12/16/2014
Aerie Pharmaceuticals, Inc. (AERI) Added To NASDAQ Biotechnology Index (NBI) 12/16/2014
EXACT Sciences Corporation (EXAS) Announces Agreement To Sell 4,000,000 Common Shares 12/16/2014
Retrophin (RTRX) Announces Addition To The NASDAQ Biotechnology Index 12/16/2014
bluebird bio (BLUE) Announces Proposed Public Offering Of Common Stock 12/16/2014
Pfizer (PFE) Declares First-Quarter 2015 Dividend 12/16/2014
Easton Pharmaceuticals (OP: EAPH) Releases Preliminary Vaporizer Related Sales Of $25,638.00 In The Month Of November 12/16/2014
ZS Pharma (ZSPH) To Ring The Nasdaq Stock Market Opening Bell 12/15/2014
Inovio Pharmaceuticals (INO) Added To NASDAQ Biotechnology Index 12/15/2014
KYTHERA Biopharmaceuticals, Inc. (KYTH) Grants Stock Options Under Inducement Program 12/15/2014
Karyopharm Therapeutics (KPTI) Announces Addition To The NASDAQ Biotechnology Index 12/15/2014
The NASDAQ OMX Group, Inc. Today Announced That Radius (RDUS) Will Be Added To Its Biotechnology Index Effective Before Market Open On Monday, December 22, 2014 12/15/2014
BioTime (BTX) To Host Investor And Analyst Day On December 15, 2014 12/15/2014
Enanta Pharmaceuticals, Inc. Added To The NASDAQ Biotechnology Index 12/15/2014
TetraPhase Pharmaceuticals Added To NASDAQ Biotechnology Index 12/15/2014
Acceleron Pharma Added To NASDAQ Biotechnology Index 12/15/2014
Concert Pharmaceuticals, Inc. (CNCE) To Be Added To NASDAQ Biotechnology Index 12/15/2014
Ophthotech Corporation (OPHT) Added To NASDAQ Biotechnology Index 12/15/2014
Enanta Pharmaceuticals, Inc. Added To The NASDAQ Biotechnology Index 12/15/2014
TetraPhase Pharmaceuticals Added To NASDAQ Biotechnology Index 12/15/2014
Acceleron Pharma Added To NASDAQ Biotechnology Index 12/15/2014
Akebia Therapeutics, Inc. (AKBA) Added To NASDAQ Biotechnology Index 12/15/2014
Flamel Technologies (FLML) To Be Included In NASDAQ Biotech Index 12/15/2014
Intuitive Surgical, Inc. (ISRG) Reports New Employee Option Grants For December 2014 12/12/2014
Flexion Therapeutics (FLXN) Announces Pricing Of Public Offering Of Common Stock 12/12/2014
Anavex Life Sciences Corp. (AVXL.OB) Upgrades To OTCQX Marketplace 12/12/2014
Rock Creek Pharmaceuticals Announces Listing Extension On NASDAQ 12/12/2014
Endo International (ENDP) Registration Statement Relating To Pending Auxilium Pharmaceuticals (AUXL) Acquisition Declared Effective By The SEC 12/12/2014
Auxilium Pharmaceuticals (AUXL) Announces Date For Special Meeting Of Stockholders 12/12/2014
Great Basin Corporation Schedules Product Roadmap Update Call And Webcast 12/12/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Announces Pricing Of Public Offering Of Common Stock 12/12/2014
Centene Corporation Announces 2015 Guidance And Confirms 2014 Guidance 12/12/2014
OvaScience (OVAS) To Host Investor Day 12/12/2014
SYGNIS AG Successfully Completes Rights Offering And Private Placement 12/12/2014
EPIRUS Biopharmaceuticals Seeks British Columbia Securities Commission Order That It Is No Longer A Reporting Issuer 12/12/2014
iBio, Inc. (IBIO) Provides Updates On Its IBIO-CFB03 Fibrosis Drug Candidate And Other Activities For The 2014 Annual Shareholders Meeting 12/12/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Announces $45 Million Proposed Public Offering 12/11/2014
IGI Laboratories, Inc. Announces Pricing Of $125 Million Of 3.75% Convertible Senior Notes Due 2019 12/11/2014
Agios Pharmaceuticals (AGIO) Announces Pricing Of $220 Million Public Offering Of Common Stock 12/11/2014
Kite Pharma, Inc. (KITE) Announces Pricing Of Follow-On Offering 12/11/2014
Trevena, Inc. (TRVN) Announces Closing Of Public Offering And Partial Exercise Of Underwriters’ Option To Purchase Additional Shares 12/11/2014
China Cord Blood Corporation Announces Results of 2014 Annual General Meeting 12/11/2014
ContraVir Pharmaceuticals' CEO Issues Letter To Shareholders Highlighting Significant Progress 12/11/2014
Valeant (VRX) To Drop Deal-Making To Cut Debt, Boost Stock 12/10/2014
Agios Pharmaceuticals (AGIO) Announces Proposed Offering Of Common Stock 12/10/2014
Analysts Not Sold On Medivation, Inc. (MDVN)’s Xtandi as Breast Cancer Drug 12/10/2014
Swedish Orphan Biovitrum CEO Geoffrey McDonough Sells A Portion Of 2014 Incentive Shares 12/9/2014
bluebird bio (BLUE)’s New Blood Treatment Could Benefit Sickle Cell, Says Analyst 12/9/2014
Galapagos NV (GLPG.BR) Increases Share Capital Through Warrant Exercises 12/9/2014
XOMA (US) LLC (XOMA) Announces Pricing Of $40.0 Million Registered Offering Of Common Stock And Warrants 12/9/2014
IntelGenx Corp. Grants Stock Options 12/9/2014
Edwards Lifesciences (EW) Outlines Growth Strategy At Annual Investor Conference 12/8/2014
Survey of Investors, Hedge Funds Blasé on Merck & Co. (MRK), Cubist Pharmaceuticals, Inc. (CBST) Deal 12/8/2014
CytoSorbents, Inc. Reports Temporary Change Of Stock Trading Symbol 12/8/2014
Onconova Therapeutics Inc. (ONTX) To Host Analyst Event In New York City On December 12, 2014 12/8/2014
Becton, Dickinson and Company (BDX) And CareFusion Corporation Announce Date Of Special Meeting In Proposed Merger 12/8/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 12/8/2014
Karolinska Development AB Release: Purchase Of Own Shares To Cover Social Security Fees Related To Incentive Program 12/8/2014
GlaxoSmithKline (GSK) Abandons Planned Sale Of Established Products Portfolio 12/5/2014
Speculation Mounts That Pfizer (PFE) Will Up Bid For AstraZeneca PLC (AZN) As Cooling Off Period Ends 12/5/2014
Henry Schein, Inc. (HSIC) Announces $300 Million Increase To Share Repurchase Plan 12/5/2014
Tute Genomics Raises $2.3 Million To Scale Up Cloud-Based Genome Analytics And Accelerate Personalized Medicine 12/5/2014
Cryo-Cell International (CCEL) Adopts Three-Year Stockholder Rights Plan 12/5/2014
BioMarin Pharmaceutical Inc. (BMRN) To Host Analyst And Investor Day On December 10th In New York 12/5/2014
Corium International, Inc. Announces Closing Of Expanded Term Loan Facility With CRG 12/5/2014
Immunomedics, Inc. (IMMU) Announces Outcome Of 2014 Annual Meeting Of Stockholders 12/5/2014
StemCells Inc. (STEM) Hosts Leading Biotech Investors And Analysts At Inaugural Event 12/5/2014
Innate Pharma (IPH.PA ) Announces Its 2015 Financial Calendar As Well As Its Participation In Upcoming Investor Conferences 12/5/2014
OncoSec Medical Inc. To Host Corporate Update Conference Call On December 9, 2014 12/5/2014
Cortendo AB Formally Informs Oslo Børs That It Will Not Pursue Oslo Axess Listing 12/5/2014
Rubicon Hints At ArborGen IPO, Laments Skidding Share Price 12/5/2014
ANI Pharmaceuticals, Inc. Announces Pricing Of Upsized $125 Million Convertible Notes Offering 12/5/2014
Champions Oncology, Inc. (CSBR) Closes Convertible Debt Financing 12/5/2014
Drug Spending Still Under 10% of American Health Costs, Says Analyst 12/5/2014
Trevena, Inc. (TRVN) Announces Pricing Of Public Offering 12/5/2014
WuXi PharmaTech Co., Ltd. Subsidiary Submits Application To The National Equities Exchange And Quotations In China To List On The New Third Board 12/4/2014
BTG plc (BTG.L) Results Of Placing 12/4/2014
ANI Pharmaceuticals, Inc. Announces $100 Million Public Offering Of Convertible Notes 12/4/2014
Becton, Dickinson and Company (BDX) To Offer Senior Unsecured Notes 12/4/2014
PDL BioPharma, Inc. (PDLI) Announces Conversion Rate Adjustments For Convertible Notes 12/4/2014
Was Your Company Hacked? Biotech Firms Rush To Deny FIN4 Breach 12/3/2014
Ocata Therapeutics Announces Proposed Underwritten Offering of Common Stock 12/3/2014
Vivione Biosciences Engages Ardour Capital As Its Exclusive Investment Banker 12/3/2014
West Pharmaceutical Services Provides Required Notice Of Automatic Conversion Of Debentures 12/3/2014
Is New Alzheimer’s Drug the Stabilizing Force Biogen Idec (BIIB) Needs? 12/3/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data 12/3/2014
Enzo Biochem (ENZ) Schedules Teleconference To Discuss First Quarter Results Wednesday, December 10, 2014 At 8:30 AM E.T. 12/3/2014
Covidien plc (COV) Release: Announcement Under Irish Takeover Rules Relevant Securities In Issue - December 3, 2014 12/3/2014
Abbott Laboratories (ABT) Attracts Bullish Trades 12/3/2014
Perrigo Company (PRGO) Announces The Closing Of Its Registered Public Offering Of Senior Notes 12/3/2014
DelMar Pharmaceuticals Joins OTCQX 12/3/2014
ChromaDex, Inc. Receives $750,000 Cash From Previous Sale Of Its Bluscience Line 12/3/2014
Can-Fite BioPharma (CFBI) Announces $8 Million At-The-Market Registered Direct Offering 12/2/2014
Race Heats Up for Best Hair in Biopharma Contest As Celgene (CELG), Acorda Therapeutics (ACOR) Square Off 12/2/2014
Shire To Highlight Pipeline Progress And Breadth Of Innovative Portfolio In R&D Day 12/2/2014
Medgenics, Inc. Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Option To Purchase Additional Shares Of Common Stock 12/2/2014
Celgene (CELG) Recommends Shareholders Reject "Mini-Tender" Offer By TRC Capital Corporation 12/2/2014
Teva Pharmaceutical Industries Limited (TEVA) To Host 2015 Business Outlook Conference Call And Webcast On December 11, 2014 12/2/2014
Nanobiotix Places Shares And Warrants With U.S. Investor 12/1/2014
Extraordinary General Meeting In Cortendo AB 12/1/2014
Number Of Outstanding Shares In Elekta AB (SE:EKTAB) 12/1/2014
Affymax, Inc. (AFFY) Adopts Tax Benefit Preservation Plan To Protect Net Operating Loss Carryforwards 12/1/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) To Host Analyst And Investor Event 12/1/2014
Tekmira (TKMR) Files Shelf Registration Statement 12/1/2014
Valeant (VRX) Announces Redemption Of US$445.0 Million Aggregate Principal Amount Of Its Outstanding 6.875% Senior Notes Due 2018 12/1/2014
Immune Pharmaceuticals, Inc. Completes Underwriter's Exercise Of Partial Over-Allotment Option 12/1/2014
Kite Pharma, Inc. (KITE) Files Registration Statement For Proposed Follow-On Offering 12/1/2014
Affymax, Inc. (AFFY) Announces A Special Cash Distribution And The Appointment Of A New Director And Chief Executive Officer 12/1/2014
Neothetics Announces Closing Of Upsized Initial Public Offering 12/1/2014
Axcelon Biopolymers Corp. Announces Closing Of Private Placement Financing In Its Woundcare Subsidiary 12/1/2014
Trevena, Inc. (TRVN) Announces Commencement Of Public Offering 12/1/2014
Roche Holdings, Inc. Announces Final Results Of Its Debt Tender Offer 12/1/2014
2015 Will Be A Defining Year for Gene Therapy, Says Analyst 12/1/2014
Cowen: With NASDAQ Index Up 33%, Biotech Remains a Winner 12/1/2014
Valeant (VRX) Announces Redemption Of US$445.0 Million Aggregate Principal Amount Of Its Outstanding 6.875% Senior Notes Due 2018 12/1/2014
University of New Hampshire Research Finds Growth In U.S. Angel Investor Market; Decrease In Deal Size 11/26/2014
Medgenics, Inc. Prices Public Offering of Common Stock 11/26/2014
Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 11/26/2014
Cynapsus Therapeutics (CYNAF) Announces Uplisting To The Toronto Stock Exchange’s Senior Equity Market 11/26/2014
Alkermes plc (ALKS)’ Corporate Presentation To Be Webcast At The NASDAQ OMX 31st Investor Program 11/26/2014
Immune Pharmaceuticals, Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 11/26/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) To Host Annual Meeting Of Stockholders 11/26/2014
NEMUS Bioscience Is Now Quoted On The OTC Bulletin Board Under The Ticker Symbol Of "NMUS" 11/26/2014
Ex-Retrophin (RTRX) CEO Sold Stock While Urging Investors To Buy 11/26/2014
Catalyst Pharmaceuticals (CPRX) CEO Outlines Biotech's 5 Phases Of Risk 11/25/2014
Analyst: First Quarter of 2015 Crucial to ProSensa Holding N.V. (RNA), BioMarin Pharmaceutical Inc. (BMRN) Deal 11/25/2014
Sarepta Therapeutics (SRPT) To Host Webcast And Conference Call For The Duchenne Muscular Dystrophy Community On December 2, 2014 11/25/2014
Investors Expect Record Year for Biotech Venture Capital 11/25/2014
Becton, Dickinson and Company (BDX) And CareFusion Corporation Announce Expiration Of HSR Act Waiting Period In Proposed Transaction 11/25/2014
Perrigo Company plc Announces The Pricing Of Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance plc 11/25/2014
Receptos (RCPT) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares And Completion Of Underwritten Public Offering Of Common Stock 11/25/2014
Becton, Dickinson and Company (BDX) Board Declares Dividend 11/25/2014
Rockwell Medical (RMTI) Closes $58.5 Million Public Offering Of Common Stock 11/25/2014
Merck & Co. (MRK) Announces Increased Quarterly Dividend 11/25/2014
AVANIR Pharmaceuticals (AVNR) Making Strides With Alzheimer’s Drug, Says Analyst 11/24/2014
Medgenics, Inc. Announces Public Offering of Common Stock 11/24/2014
Conatus Pharmaceuticals Inc. To Present At Two December Investor Conferences 11/24/2014
CollabRx, Inc. Announces Receipt Of NASDAQ Notice Of Bid Price Deficiency 11/24/2014
Amicus Therapeutics, Inc. (FOLD) Announces Closing Of Underwritten Offering Of Common Stock And Full Exercise Of Over-Allotment Option 11/24/2014
Perrigo Company plc Announces Proposed Public Offering Of Senior Notes Of Its Finance Subsidiary, Perrigo Finance plc 11/24/2014
Perrigo Company plc Announces Underwriters' Full Exercise Of Option To Purchase Ordinary Shares In Connection With The Equity Offering 11/24/2014
Marrone Bio Innovations, Inc Receives NASDAQ Notice Regarding Late Form 10-Q Filing 11/24/2014
OnCore Biopharma Announces Confidential Submission Of Draft Registration Statement For Initial Public Offering 11/24/2014
PlasmaTech Biopharmaceuticals, Inc. Announces Stock Ticker Symbol Change To PTBI 11/24/2014
Proteon Therapeutics, Inc. (PRTO) Announces The Closing Of Initial Public Offering And The Underwriters' Option To Purchase Additional Shares 11/24/2014
Tekmira (TKMR) Provides Key Highlights Of Analyst And Investor Day In New York 11/24/2014
Bayer AG (BAYZF) To Use IPO Funds To Cut Debt And Buy Consumer Drugs 11/24/2014
BioMarin Pharmaceutical Inc. (BMRN), ProSensa Holding N.V. (RNA) Marriage Makes Sense for Investors If Regulatory Hurdles Can Be Overcome 11/24/2014
EXCLUSIVE: Ackman Says “Biggest Mistake” In Allergan (AGN) Bid Was Tender Offer 11/21/2014
Cytori Therapeutics, Inc. (CYTX) To Provide Corporate Update And Investor Presentation On December 4 Through A Live, Interactive Webcast 11/21/2014
Perrigo Company Plc Announces The Pricing Of Its Offering Of Ordinary Shares 11/21/2014
Lexicon Pharmaceuticals, Inc. (LXRX) Announces Pricing Of Common Stock Offering 11/21/2014
Agilent Technologies Inc. (A) Announces Cash Dividend Of 10 Cents Per Share 11/21/2014
Neovacs SA Secures A New Equity Line Financing With Kepler Cheuvreux 11/21/2014
Solid Lymphoma Data Points To Larger Potential For Epizyme (EPZM), Says Citi 11/21/2014
ZS Pharma (ZSPH) Hosts And Webcasts Investor Event 11/20/2014
StemCells Inc. (STEM)To Host Inaugural Investor And Analyst Event In New York 11/20/2014
Matinas BioPharma To Present At Two Investor Conferences In Early December 11/20/2014
MYOS (MYOS) Announces $1.81 Million Registered Direct Offering 11/20/2014
Cowen: Acorda Therapeutics (ACOR) Not Worried About Civitas Therapeutics' New Parkinson's Drug 11/20/2014
Rockwell Medical (RMTI) Prices $58.5 Million Public Offering Of Common Stock 11/20/2014
Perrigo Company plc Announces Proposed Public Offering Of Ordinary Shares 11/20/2014